$RDVT

MacLachlan Daniel sold $346K of RDVT

MacLachlan Daniel (Chief Financial Officer) sold 6,000 shares of Red Violet, Inc. (RDVT) at $57.62 ($0.35M total) on 2026-06-01.

Original reporting
SEC EDGAR · MacLachlan Daniel
Published Jun 1, 2026, 11:41 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 11:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RDVT
Bearish
medium confidence
Mentioned
$RDVT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RDVTBearishLow
01

Why it matters

Traders may briefly reassess near-term sentiment, but the filing does not include new business, financial, or regulatory developments.

02

Market read

Insider selling can influence short-term sentiment, but the event lacks fundamental context (no guidance, deal, or earnings update).

03

What to watch

Compare with prior insider activity trends and any concurrent operational/news catalysts; a single Form 4 often has low explanatory power.

Relevance 6/10Novelty 6/10Timing: Filed/dated 2026-06-01 (same day as sale disclosure).

Background

This is an SEC Form 4 insider transaction disclosure for Red Violet, Inc., reported by its CFO.

Company-level read

Ticker impact

$RDVTBearishMedium confidence
Context

Red Violet CFO MacLachlan Daniel sold 6,000 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-01.

Expected impact

Likely small/short-lived negative drift or no sustained move; watch for follow-on selling or other catalysts.

Evidence & confidence

The filing is a routine insider transaction (not a 10b5-1 plan) with a defined sale price, but insider sales alone rarely drive durable repricing absent additional company-specific news.

Market effects

Minimal—this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The sale may be for diversification, taxes, or pre-planned liquidity needs; absence of a 10b5-1 plan doesn’t automatically imply bearish fundamentals.

Key entities

  • Red Violet, Inc.

    Subject of the insider transaction disclosure (CFO MacLachlan Daniel sold shares).

  • MacLachlan Daniel

    CFO who reported the open-market sale of 6,000 shares.

Related articles

$RDVTMedAI 8/10

red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters' Option

Red Violet, Inc. (NASDAQ: RDVT) said it closed an underwritten public offering of 1,916,667 shares of common stock, including 250,000 shares from full exercise of the underwriters’ option. The company estimates net proceeds of about $108.6 million. Proceeds will be used for working capital, general corporate purposes, and potential strategic acquisitions.

$RDVTMedAI 8/10

red violet Announces Pricing of $100 Million Underwritten Public Offering of Common Stock

Red Violet, Inc. (NASDAQ: RDVT) priced an underwritten public offering of 1,666,667 shares of common stock at $60.00 per share, raising expected gross proceeds of $100 million before underwriting fees and expenses. The offering is expected to close Aug. 7, 2026, with a 30-day option for up to 250,000 additional shares. Net proceeds will fund working capital and corporate purposes.